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Orally ingested bacteria interact with intestinal mucosa and may impact immunity. 
However, insights in mechanisms involved are limited. In this randomized placebo- 
controlled cross-over trial, healthy human subjects were given Lactobacillus plantarum 
supplementation (strain TIFN101, CIP104448, or WCFS1) or placebo for 7  days. To 
determine whether L. plantarum can enhance immune response, we compared the 
effects of three stains on systemic and gut mucosal immunity, by among others assessing 
memory responses against tetanus toxoid (TT)-antigen, and mucosal gene transcription, 
in human volunteers during induction of mild immune stressor in the intestine, by giving a 
commonly used enteropathic drug, indomethacin [non-steroidal anti-inflammatory drug 
(NSAID)]. Systemic effects of the interventions were studies in peripheral blood samples. 
NSAID was found to induce a reduction in serum CD4+/Foxp3 regulatory cells, which 
was prevented by L. plantarum TIFN101. T-cell polarization experiments showed L. plan-
tarum TIFN101 to enhance responses against TT-antigen, which indicates stimulation 
of memory responses by this strain. Cell extracts of the specific L. plantarum strains 
provoked responses after WCFS1 and TIFN101 consumption, indicating stimulation of 
immune responses against the specific bacteria. Mucosal immunomodulatory effects 
were studied in duodenal biopsies. In small intestinal mucosa, TIFN101 upregulated 
genes associated with maintenance of T- and B-cell function and antigen presenta-
tion. Furthermore, L. plantarum TIFN101 and WCFS1 downregulated immunological 
pathways involved in antigen presentation and shared downregulation of snoRNAs, 
which may suggest cellular destabilization, but may also be an indicator of tissue repair. 
Full sequencing of the L. plantarum strains revealed possible gene clusters that might 
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be responsible for the differential biological effects of the bacteria on host immunity. 
In conclusion, the impact of oral consumption L. plantarum on host immunity is strain 
dependent and involves responses against bacterial cell components. Some strains may 
enhance specific responses against pathogens by enhancing antigen presentation and 
leukocyte maintenance in mucosa. In future studies and clinical settings, caution should 
be taken in selecting beneficial bacteria as closely related strains can have different 
effects. Our data show that specific bacterial strains can prevent immune stress induced 
by commonly consumed painkillers such as NSAID and can have enhancing beneficial 
effects on immunity of consumers by stimulating antigen presentation and memory 
responses.
Keywords: intestinal mucosal immunity, adaptive immunity, Lactobacillus plantarum, indomethacin, non-steroidal 
anti-inflammatory drug, probiotics
inTrODUCTiOn
Commensal Lactobacilli species may play an active role in 
intestinal immune homeostasis (1–9). Lactobacilli likely regulate 
immune cells via the interaction of bacterial cell-wall compo-
nents or secreted bacterial products with immune or epithelial 
cells in human gut mucosa (8, 10, 11). These interactions seem to 
contribute to more than just tolerance to the beneficial microbes. 
As demonstrated in several vaccination studies Lactobacilli, such 
as plantarum strains derived from WCFS1, have a positive impact 
on immune responses (12–18). Furthermore, these bacteria 
can activate tolerogenic cellular pathways in human intestinal 
mucosal cells (3, 5, 10).
In previous studies, we demonstrated that Lactobacillus 
plantarum, a member of lactic acid bacteria with a “generally 
recognized as safe” status (3, 19), had different effects on human 
dendritic and peripheral blood mononuclear cells (10, 11). 
Using comparative genomic hybridization, we identified a 
number of bacteriocins and cell-wall components involved 
in the glycosylation of cell wall teichoic acids associated with 
these differential effects (8, 10). The differential expression of 
L. plantarum genes may contribute to the observed differences 
in activation of toll-like receptor (TLR) 2–4 and CD14 antigens 
in the host (10). As a consequence of differences in TLR-binding 
dendritic cells L. plantarum strains induce alterations in pro-
duction of the pro-inflammatory cytokine IL-12 and the regu-
latory cytokine IL-10 (10). The immunomodulatory effects of 
L. plantarum may benefit human gut homeostasis, in particular 
in case of pathogenic or pharmacological induced mucosal 
stress. Non-steroidal anti-inflammatory drugs (NSAIDs), 
which are commonly used painkillers, are well known for their 
negative side effects on gut mucosal integrity and immunity, 
which are mediated through inhibition of cyclooxygenase and 
subsequent prostaglandin deficiency. But these effects have also 
been shown to be modulated by gut microbiota via among others 
TLR4 signaling (20).
The current clinical trial has been conducted to study the 
effects of three L. plantarum strains on immunity and intestinal 
barrier function. The findings regarding immune responses are 
presented in the current report, while the results on gut barrier 
function have been published previously (2). We have shown that 
small intestinal permeability of healthy volunteers increased, 
indicating gut barrier dysfunction, after administration of indo-
methacin (a NSAID) which could not be reversed by intake of 
L. plantarum strains. However, one of the strains, i.e., L. plan­
tarum TIFN101, did demonstrate profound effects on mucosal 
gene transcription related to mucosal structure, while the find-
ings regarding the modulation of these processes by L. plantarum 
WCFS1 and CIP4448 were more moderate. This indicates strain-
dependent modulation of gut barrier function by the tested 
L. plantarum strains (2).
To investigate mechanism by which L. plantarum may influ-
ence in vivo human mucosal and systemic immune activity under 
mild mucosal stress conditions such as intake of NSAIDs, we con-
ducted a randomized double-blind placebo-controlled cross-over 
human trial. Three L. plantarum strains were selected for their 
different immunomodulating effect in vitro (3, 10, 11). The three 
strains have different effects on TLRs signaling and differently 
stimulate cytokine production in vitro in immune cells (3, 10, 11). 
Healthy volunteers received the NSAID indomethacin, which 
induces mild and reversible damage to the gastrointestinal lining 
(21–24). Study participants subsequently consumed one of the 
three L. plantarum strains or placebo for a week. Polarized T-cell 
responses in the peripheral circulation, as well as the responses 
after re-stimulation with cell extract of L. plantarum strains, 
superantigen, or tetanus were studied to determine whether 
these bacteria could enhance systemic immunity against one of 
the stimuli. Duodenal biopsies were taken and used to study the 
effect of the strains on mucosal gene regulation. Furthermore, 
the bacterial strains were sequenced and annotated to identify 
putative gene clusters associated with the differential responses 
induced by the probiotics.
MaTErialS anD METHODS
This study was approved by the University Hospital Maastricht 
Ethical Committee and has been registered in the US National 
Library of Medicine (NCT01456767).1 A more detailed descrip-
tion of the trial design has been published previously (2).
1 http://www.clinicaltrials.gov.
FigUrE 1 | Effects of three Lactobacillus plantarum strains on the frequency of CD4+ T-cell populations in systemic circulation. Data are expressed as mean ± SEM. 
Statistical significant differences were determined by using two-sided Student’s t-tests. A p-value <0.05 was considered statistically significant. A p-value <0.1 was 
considered a statistical trend.
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Study Design and Study Participants
Ten healthy volunteers, seven females and three males 
(26.3 ± 10.1 years, BMI of 21.8 ± 2.40 kg/m2), without a history of 
gastrointestinal symptoms and free of medication, were tested on 
four separate occasions in a randomized cross-over design. Four 
intervention periods included the 7-day intake of L. plantarum 
FigUrE 2 | Effects of three Lactobacillus plantarum strains on the frequency of CD8+ T-cell populations in systemic circulation. Data are expressed as mean ± SEM. 
Statistical significant differences were determined by using two-sided Student’s t-tests. A p-value <0.05 was considered statistically significant. A p-value <0.1 was 
considered a statistical trend.
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strains WCFS1 (WCFS), CIP104448 (CIP48), or TIFN101, or 
placebo. Before and after the intervention, blood samples were 
taken to study the effect of L. plantarum consumption on T-cell 
polarization. Furthermore, at day 7, duodenal biopsies were taken 
for whole-genome expression microarrays. No side effects or 
complications were reported.
All included subjects gave their written informed consent. The 
healthy volunteers consumed their habitual diet and kept a gastro-
intestinal symptoms diary. The night before the start day, the vol-
unteers ingested 75 mg of the NSAID indomethacin. On the start 
day, the volunteers ingested another dosage of 50 mg indometha-
cin to conform to a previously established protocol to establish 
mild gastrointestinal mucosal stress (25, 26). Subsequently, the 
volunteers consumed the bacterium or placebo supplements for 
a period of 7 days during breakfast and during dinner. The vials 
containing bacteria or placebo were non-transparent. On the sev-
enth day, blood samples were taken again and tissue samples were 
obtained from the horizontal part of the duodenum by standard 
flexible gastroduodenoscopy at approximately 15 cm distal to the 
pylorus. The duodenal mucosa was chosen as the duodenum is 
readily accessible for sampling. The interventions were performed 
with an interval of 4 weeks to allow a wash-out period and also 
healing of the biopsy-sampling region.
Bacterial Strains and growth Conditions
Three L. plantarum strains form the NIZO strain-collection were 
selected: WCFS1, CIP104448, and TIFN101. In previous studies 
TIFN101 has been referred to as CIP104450 (11, 27). The bac-
teria were cultured at 37°C in man, rogosa, and sharpe medium 
(Merck). Detailed protocols for culturing, harvesting, freeze dry-
ing, storing, and viability determination of Lactobacillus species 
have been published (1). Maltodextrin and glucose were added to 
a final concentration of 20 and 2% (wt/vol), respectively, to obtain 
bacterial preparations (WCFS1, 2.6  ×  109  CFU; CIP104448, 
2.4 × 109 CFU; and TIFN101, 5.6 × 109 CFU); placebo controls 
contained the two sugars.
Cell Staining
Blood of study participants was collected in EDTA-containing 
tubes and processed for fluorescence-activated cell sorting 
(FACS) analysis (Table S1 in Supplementary Material). Isotype 
controls were used at the same dilution as the antibody.
FigUrE 3 | Effects of three Lactobacillus plantarum strains on the frequency of IL-21, IL-17, IL-4, and IFN-γ-producing Staphylococcus aureus enterotoxin B 
superantigen (SEB)-stimulated memory-CD45RO+ Th cells. Data are expressed as mean ± SEM. Statistical significant differences were determined by using 
two-sided Student’s t-tests. A p-value <0.05 was considered statistically significant. A p-value <0.1 was considered a statistical trend.
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To study T-cell polarization, 200  µl of blood was diluted 
with 200  µl of RPMI1640 supplemented with heat-inactivated 
10% fetal calf serum (FCS) and incubated with either phorbol-
myristate-acetate (PMA; 80  nM Sigma-Aldrich, Steinheim, 
Germany) and 2 nM calcium ionophore (Ca-Io; Sigma-Aldrich) 
(4  h), Staphylococcus aureus-enterotoxin B (SEB) (5  µg/ml 
Sigma, Deisenhofen, Germany) (24  h), tetanus toxoid (TT; 1.5 
Lf/ml, RIVM, Bilthoven, The Netherlands) (24  h), or bacterial 
lysates (30 µg/ml) (24 h). Stimulation with bacterial lysates was 
performed 1 week after treatment with one of the three strains. 
After stimulation, red blood cells were lysed with ammonium 
chloride, washed (PBS with 2% FCS), and incubated with differ-
ent antibody cocktails.
To stain for T-cells and T-cell subsets, cells were incubated 
with an antibody cocktail consisting of anti-CD3, anti-CD8, and 
anti-CD45RO for 30 min in the dark on ice. After washing with 
buffer, cells were incubated with streptavidin-Pacific Orange 
(1:100 Invitrogen) for 15  min on ice. After washing and cen-
trifugation, pelleted cells were resuspended in Fix/Perm solution 
(eBioscience) for 45 min on ice. After washing in Perm-solution 
cells were incubated in mouse-serum for 15  min, followed by 
incubation with the cytokine antibody mix (anti-IL-4, anti-IFNγ, 
anti-IL-17, and anti-IL-21) or an isotype control mix for 30 min 
on ice. Cells were then washed with Perm solution (three times), 
resuspended in wash-buffer and measured by flow-cytometry.
For staining NK-cells, cells were incubated with an antibody 
cocktail consisting of anti-CD3, anti-CD16, anti-CD56, anti-
CD335, and anti-CD161 (NK-cell staining), or with an isotype 
control cocktail for NK-cells consisting of anti-CD3, anti-CD16, 
anti-CD56, and isotype controls for anti-CD335 and CD161 for 
30 min in the dark on ice. After washing with washing buffer, cells 
were fixed in FACS-lysis solution (BD Biosciences) for 30 min on 
ice, washed and analyzed by flow-cytometry.
rna isolation and Microarray
Total RNA was isolated from duodenal biopsy samples of the 
study participants using Trizol reagent (1  ml) (Invitrogen, 
Breda, The Netherlands). RNA was purified using the Qiagen 
RNeasy Micro kit (Qiagen, The Netherlands) and quantified on 
a NanoDrop ND-1000 spectrophotometer (Isogen Life Science, 
The Netherlands). RNA quality was confirmed using an Agilent 
2100 bioanalyzer (Agilent Technologies, The Netherlands). RNA 
FigUrE 4 | Effects of three Lactobacillus plantarum strains on the frequency of IL-21, IL-17, IL-4, and IFN-γ-producing tetanus toxoid-stimulated memory-
CD45RO+ Th cells. Data are expressed as mean ± SEM. Statistical significant differences were determined by using two-sided Student’s t-tests. A p-value <0.05 
was considered statistically significant. A p-value <0.1 was considered a statistical trend.
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was judged suitable for array-hybridization only if samples exhib-
ited intact bands corresponding to 18S and 28S ribosomal subu-
nits and displayed no chromosomal peaks or RNA-degradation 
products.
Total RNA (100 ng) was used for whole transcript cDNA syn-
thesis using the Ambion WT expression kit (Life Technologies, 
The Netherlands) and was subsequently labeled using the 
Affymetrix GeneChip WT Terminal Labeling Kit (Affymetrix, 
Santa Clara, CA, USA). Samples were hybridized to human 
whole genome Affymetrix GeneChip Human Gene 1.1 ST arrays, 
washed, stained, and scanned on an Affymetrix GeneTitan instru-
ment. Details on array handling can be found in the Affymetrix 
GeneTitan Instrument User Guide for Expression Array Plates 
(P/N 702933 Rev.2).
Duodenal Mucosa Microarray Data 
analysis
Microarray analysis was performed utilizing MADMAX for 
statistical analysis (28). All arrays met the quality criteria. 
The probes on the Human Gene 1.1 ST arrays were redefined 
according to Dai et al. (29) based on the NCBI Entrez database 
(CDF version 15.1). In this way, the Human Gene 1.1 ST array 
targets 19,682 unique genes. Normalized expression values 
were obtained from the raw intensity values by using the robust 
multi-array analysis preprocessing algorithm available in the 
AffyPLM library using default settings (30). Microarray data were 
filtered and probe sets with at least five probes and expression 
values higher than 20 on at least five arrays with an interquartile 
range (IQR) >0.2 (log2 scale) across all samples were selected 
for further statistical analysis. In addition, an IQR cut-off of 0.2 
was used to filter out genes that showed no variation between the 
conditions. Differentially expressed genes were identified using 
linear models, applying moderated t-statistics that implemented 
empirical Bayes regularization of SEs in the library limma (31). 
The moderated t-statistic was extended by a Bayesian hierarchical 
model to define an intensity-based moderated t-statistic to adjust 
for independence of variances relative to the degree of identity and 
relation between variance and signal intensity (32). Genes were 
defined as significantly changed when the p-value was <0.05 for 
FigUrE 5 | Effects of three Lactobacillus plantarum strains on the frequency of IL-21, IL-17, IL-4, and IFN-γ-producing memory-CD45RO+ Th cells stimulated with 
bacterial cell extracts, matched to the strain consumed. Data are expressed as mean ± SEM. Statistical significant differences were determined by using two-sided 
Student’s t-tests. A p-value <0.05 was considered statistically significant. A p-value <0.1 was considered a statistical trend.
FigUrE 6 | Flowchart of the microarray analysis (a) and the number of unique genes regulated in human intestinal biopsies after consumption of three different 
Lactobacillus plantarum strains [L. plantarum WCFS1 (WCFS), L. plantarum CIP104448 (CIP48), L. plantarum TIFN101 (TIFN101)]. Intensity >20 on at least five 
arrays, interquartile range >0.2, at least seven probes per gene. Venn diagrams of the number of upregulated (B) and downregulated (C) genes in the intestinal 
biopsies after consumption of L. plantarum and indomethacin.
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TaBlE 2 | Lactobacillus plantarum CIP104448 (CIP48): 10 most upregulated 
and downregulated genes.
gene 
name
iBMT 
p-
value
Mean 
fold 
versus 
placebo 
Top 10: upregulated genes placebo versus CiP48
Coiled-coil domain containing 59 CCDC59 0.01 1.33
Aldehyde dehydrogenase 1 family, member L2 ALDH1L2 0.03 1.32
KIAA0125 KIAA0125 0.00 1.31
Phospholipase C, beta 4 PLCB4 0.01 1.31
Coiled-coil domain containing 102B CCDC102B 0.04 1.29
RAS guanyl releasing protein 3 (calcium and 
DAG-regulated)
RASGRP3 0.03 1.28
Peptidase domain containing associated with 
muscle regeneration 1
PAMR1 0.00 1.28
DEP domain containing 1 DEPDC1 0.01 1.28
Phospholipase A2, group IIA (platelets, synovial 
fluid)
PLA2G2A 0.02 1.28
Heparan sulfate (glucosamine) 
3-O-sulfotransferase 3B1
HS3ST3B1 0.04 1.28
Top 10: downregulated genes placebo versus CiP48
Potassium channel, subfamily K, member 15 KCNK15 0.05 −1.33
Transient receptor potential cation channel, 
subfamily V, member 6
TRPV6 0.01 −1.33
Long intergenic non-protein coding RNA 282 LINC00282 0.03 −1.35
Ephrin-A1 EFNA1 0.02 −1.38
Matrix metallopeptidase 10 (stromelysin 2) MMP10 0.05 −1.41
Angiopoietin-like 4 ANGPTL4 0.03 −1.47
Heme oxygenase (decycling) 1 HMOX1 0.00 −1.50
Nuclear factor, interleukin 3 regulated NFIL3 0.01 −1.52
Major facilitator superfamily domain containing 
2A
MFSD2A 0.02 −1.59
Glucose-6-phosphatase, catalytic subunit G6PC 0.02 −1.65
TaBlE 1 | Lactobacillus plantarum WCFS1 (WCSF): 10 most upregulated and 
downregulated genes.
gene name iBMT 
p-value
Mean fold 
versus 
placebo
Top 10: upregulated genes placebo versus WCFS
Kinesin family member 20B KIF20B 0.01 1.34
microRNA 186 MIR186 0.03 1.31
Guanylate cyclase activator 2A (guanylin) GUCA2A 0.04 1.31
Integrin, alpha 4 (antigen CD49D, alpha 4 
subunit of VLA-4 receptor)
ITGA4 0.01 1.31
Centromere protein E, 312 kDa CENPE 0.05 1.30
Putative homeodomain  
transcription factor 1
PHTF1 0.00 1.30
Spindle and kinetochore-associated  
complex subunit 2
SKA2 0.01 1.29
Killer cell lectin-like receptor subfamily D, 
member 1
KLRD1 0.00 1.29
Gamma-aminobutyric acid A  
receptor, alpha 2
GABRA2 0.02 1.27
Retinitis pigmentosa GTPase regulator RPGR 0.01 1.27
Top 10: downregulated genes placebo versus WCFS
Small nucleolar RNA, H/ACA box 16A SNORA16A 0.02 −1.35
Small nucleolar RNA, C/D box 53 SNORD53 0.04 −1.36
Contactin 3 (plasmacytoma associated) CNTN3 0.00 −1.38
Small nucleolar RNA, C/D box 6 SNORD6 0.04 −1.39
Small nucleolar RNA, H/ACA box 57 SNORA57 0.00 −1.44
Small nucleolar RNA, H/ACA box 60 SNORA60 0.00 −1.44
Small nucleolar RNA, H/ACA box 14A SNORA14A 0.03 −1.49
Small nucleolar RNA, H/ACA box 38B 
(retrotransposed)
SNORA38B 0.01 −1.58
Small nucleolar RNA, H/ACA box 14B SNORA14B 0.01 −1.58
Small Cajal body-specific RNA 4 SNORA16A 0.01 −1.72
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pairwise comparisons. The datasets generated from microarray 
profiling experiments have been deposited to the publicly acces-
sible database repository Gene Expression Omnibus (GSE74988).
Pathway analysis
Gene set enrichment analysis (GSEA2) was performed using 
MADMAX and gene sets with a false discovery rate <0.2 were 
considered significantly enriched. GSEA takes into account the 
broader context in which gene products function, namely in 
physically interacting networks such as biochemical, metabolic, 
or signal transduction routes, and has the advantage that it 
is unbiased because no gene selection step is used. Possible 
transcription factors were identified using upstream regulator 
analysis in ingenuity pathway analysis (IPA; Ingenuity Systems, 
Redwood City, CA, USA).
Bacterial genome Sequencing and 
annotation
For DNA preparation, bacteria were pelleted, washed, and 
resuspended in TES buffer (N-[tris(hydroxymethyl)methyl]-
2-aminoet hanesulfonic acid). Cells were lysed with lysozyme 
(360  mg/ml) and mutanolysin (140  U/ml) by incubation for 
2 h at 37°C. Subsequently, 300 µl water and 80 µl of a 20% SDS 
2 http://broad.mit.edu/gsea/.
solution were added. The DNA extraction was done using phenol/
chloroform (3×). DNA was precipitated with isopropanol and 
washed with 70% ethanol. Samples were treated with 100 µg/ml 
RNAse (Sigma) for 1 h at 37°C. DNA paired-end libraries with 
barcoding were made and sequenced using Illumina technol-
ogy (Baseclear Leiden). The genome sequences of L. plantarum 
strains CIP104448 and TIFN 101 have been deposited in 
NCBI/GenBank under accession numbers JSUW00000000 and 
JSUX00000000, respectively. The contig sequences were submit-
ted to the RAST automatic annotation server,3 which provided 
ORF calling and automatic annotation. The annotated contigs 
of CIP48 and TIFN101 were ordered by comparing them to 
the circular template genome of L. plantarum WCFS1 (33), and 
comparing them to each other. Contigs/genes that did not match 
to the WCFS1 genome were annotated in more detail using 
BLASTP4 and InterProscan.5 Ortholog groups (OGs) in the three 
genomes were determined using OrthoMCL.6
Statistics
Flow-cytometry results are expressed as the mean ± SEM. Normal 
distribution was confirmed by the Kolmogorov–Smirnov test. 
3 http://rast.nmpdr.org/.
4 http://blast.ncbi.nlm.nih.gov/.
5 http://www.ebi.ac.uk/interpro/.
6 http://www.orthomcl.org/.
TaBlE 3 | Lactobacillus plantarum TIFN101 (TIFN101): 10 most upregulated and 
downregulated genes.
gene name iBMT 
p-value
Mean fold 
versus 
placebo
Top 10: upregulated genes placebo versus TiFn101
Immunoglobulin lambda variable 6–57 IGLV6-57 0.01 1.63
Putative V-set and immunoglobulin  
domain-containing protein 6-like
LOC642131 0.00 1.55
Immunoglobulin lambda variable  
7–46 (gene/pseudogene)
IGLV7-46 0.04 1.48
Heparan sulfate (glucosamine) 
3-O-sulfotransferase 3B1
HS3ST3B1 0.00 1.41
Interferon regulatory factor 4 IRF4 0.00 1.40
GDNF family receptor alpha 2 GFRA2 0.00 1.40
CD27 molecule CD27 0.01 1.40
CD79a molecule, immunoglobulin- 
associated alpha
CD79A 0.03 1.38
Plasminogen activator, tissue PLAT 0.00 1.37
Der1-like domain family, member 3 DERL3 0.00 1.37
Top 10: downregulated genes placebo versus TiFn101
Small nucleolar RNA, H/ACA box 38B 
(retrotransposed)
SNORA38B 0.04 −1.40
Small nucleolar RNA, H/ACA box 21 SNORA21 0.03 −1.40
Small nucleolar RNA, H/ACA box 60 SNORA60 0.01 −1.41
Small nucleolar RNA, C/D box 53 SNORD53 0.01 −1.43
Ephrin-A1 EFNA1 0.00 −1.45
Small nucleolar RNA, C/D box 6 SNORD6 0.02 −1.46
Small nucleolar RNA, H/ACA box 57 SNORA57 0.00 −1.47
Small nucleolar RNA, H/ACA box 14B SNORA14B 0.00 −1.73
Family with sequence similarity 5,  
member C
FAM5C 0.03 −1.97
Small Cajal body-specific RNA 4 SCARNA4 0.00 −2.00
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The two-sided Student’s t-test was used for changes in immune-
cell populations after L. plantarum treatment. Gene expression 
data are depicted as the median (range). The two-sided Mann–
Whitney U-test was used to determine changes in expression 
profiles after L. plantarum treatment in vivo. A p-value <0.05 was 
considered statistically significant.
rESUlTS
Cell Frequencies and T-Cell Polarization 
after Treatment with L. plantarum Strains
In peripheral blood samples, we did not observe differences 
in the frequencies of total CD3+ cells, CD3+CD4+ cells (naïve 
or memory), or the CD3+CD4+ activated memory cells after 
treatment with any of the L. plantarum strains. However, the 
percentage of CD4+Foxp3+ cells was significantly decreased 
following placebo and CIP48 treatment, but not after TIFN101 
treatment (Figure 1). Moreover, although we did not observe 
any effect with indomethacin treatment on CD3+CD8+ (naïve 
and memory) cells, activated memory-cells exhibited a statis-
tically significantly decrease after CIP48 treatment (p < 0.05) 
(Figure 2).
Treatment did not influence percentages of NK-cells or NKT-
cells. There was also no change in the percentages of the NK-cell 
subtypes (i.e., CD56high and CD56dim); and the expression of 
CD161 (KLRB1), mediating cytotoxicity (33, 34), was not affected 
either by the L. plantarum treatments (results not shown).
T-cell polarization was studied after three types of T-cell 
stimulation: (i) non-specific polyclonal stimulation with PMA/
Ca2+ or superantigen Staphylococcus aureus-enterotoxin B (SEB) 
to study whether the total responsiveness was influenced by 
L. plantarum treatment, (ii) stimulation with a previously 
administered vaccine-antigen (TT) to study stimulation of spe-
cific memory responses, and (iii) stimulation with cell extracts 
of the specific L. plantarum strains in order to investigate 
whether specific immune responses against the L. plantarum 
were stimulated.
After non-specific stimulation with PMA/Ca-ionophore or 
SEB, we quantified the percentage of IFNγ, IL-4, IL-17, or IL-21 
positive Th cells and memory Th cells. Treatment with placebo or 
the administered L. plantarum strains did not influence cytokine 
production of the total population of Th cells or of Th memory 
cells after non-specific stimulation with PMA/Ca-ionophore. 
Although no differences were found after SEB-stimulation in 
cytokine production by the total Th cell population after the three 
L. plantarum treatments (results not shown), we did observe 
differences in cytokine production of the Th memory cells after 
L. plantarum treatment. After stimulation with SEB, we observed 
a decreased percentage of IL-17-producing activated memory Th 
cells following treatment with CIP48 and an increased percentage 
of IL-17-producing activated memory Th cells after treatment 
with TIFN101 (Figure  3). Moreover, the percentage of IFNγ-
producing activated memory Th cells was also increased after 
TIFN101 treatment (Figure 3).
Treatment with L. plantarum strains also modulated cytokine 
production following a more specific stimulation by TT (Figure 4). 
After TIFN101 treatment, the percentage IL-17 and the percentage 
IFN-γ-producing memory Th cells were significantly increased, 
while no effect on cytokine production by memory Th cells after 
TT-stimulation was observed with the other L. plantarum strains.
Finally, we stimulated human blood samples with cell extracts 
of the L. plantarum strain that the volunteers had consumed in 
the study (Figure 5). We observed that subjects, who were treated 
with WCFS, showed a trend toward an increased IL-17 response 
after stimulation with WCFS cell extracts. Other cytokines were 
not affected after this treatment. There were no differences in 
cytokine production in subjects treated with CIP48, when their 
blood samples were stimulated with CIP48 cell extract. When 
subjects were treated with TIFN101, their activated memory 
cells exhibited increased IL-17 and IFN-γ-production following 
stimulation with TIFN101 cell extract.
Transcriptional response in Duodenal 
Mucosa upon Exposure to L. plantarum 
Strains
Differential gene expression profiles were found in the stressed 
intestinal mucosa of the subjects consuming each bacterial strain; 
315 genes were differentially regulated with L. plantarum WCFS, 
390 with CIP48, and 779 with TIFN101, as compared to the pla-
cebo intervention (Figure 6A). Of these genes, the different bac-
terial strains shared only relatively small numbers of upregulated 
FigUrE 7 | Cellular pathways are significantly more modulated after consumption of either Lactobacillus plantarum TIFN101 (dark blue, left column) than after 
consumption of L. plantarum CIP104448 (light blue, middle column) or L. plantarum WCFS1 (cyan, right column). Statistical significance of pathway modulation was 
calculated via a right-tailed Fisher’s Exact test in ingenuity pathway analysis and represented as −log (p-value); −log values exceeding the depicted threshold were 
significant (p < 0.05).
10
de Vos et al. Lactobacilli and Human Immunity
Frontiers in Immunology | www.frontiersin.org August 2017 | Volume 8 | Article 1000
and downregulated genes (Figures  6B,C, respectively). Shared 
genes were mainly involved in general cellular functions and 
metabolism.
The 10 genes that were most highly up- or downregulated 
are listed in Tables 1–3. Of the most highly induced genes after 
TIFN101 consumption 80% are related to immunity: immuno-
globulin lambda variable 6–57, putative V-set and immunoglob-
ulin domain-containing protein 6-like, immunoglobulin lambda 
variable 7–46, interferon regulatory factor 4, GDNF family, CD27, 
CD79a, and plasminogen activator. WCFS and TIFN101 shared 
the downregulation of six small nucleolar RNAs, i.e., snoRNA 
(H)C/D(ACA) box 6, 14b, 53, 57, 60, 388, while CIP48 had a 
complete different profile of up and downregulation.
To identify specific transcription factors and to identify 
pathways regulated by the strains, IPA was performed (Figure 7). 
TIFN101 induced more changes than CIP48 and WCSF1 in the 
NSAID-stressed intestine. The most significant set of target-genes 
in the TIFN101 group were immune response-related genes. 
TIFN101 upregulated MHC-IIα, while CIP48 and WCFS down-
regulated MHC-IIβ (Figure 8). Another pathway that might con-
tribute to the enhanced responses in TIFN101 is the upregulation 
of genes involved in leukocyte extravasation (Figure 9). TIFN101 
enhanced RAPL expression, which is a GTPase involved in 
regulating integrin affinity. Concomitantly, an upregulation of 
essential adhesion molecules such as ICAM-1 and Cadherin 5 
was seen, illustrating the upregulation of immune-cell migra-
tion pathways by TIFN101. Also, some regulation of leukocyte 
extravasation was observed with CIP48 and WCFS. However, it 
was much less pronounced than for the TIFN101 intervention.
Differential gene Content Profiles between 
the Three L. plantarum Strains
Lactobacillus plantarum strains CIP48 and TIFN101 were 
sequenced, annotated, and compared with the genome (chromo-
some and plasmids) of L. plantarum WCFS1 (35, 36). A total of 
3,010 OGs were assigned to the chromosome, based on the order-
ing of contigs to the template WCFS genome. The three genomes 
shared 2,455 of the 3,010 chromosomal OGs (=81.5%), which is 
defined as the core genome for this study. Figure 10 presents the 
shared and genes and contigs of the L. plantarum strains. When 
the contigs and OGs/genes are included that do not match to the 
WCFS chromosome, higher numbers of unique genes were found 
for the CIP48 and TIFN101 genomes. Many of these extra unique 
genes are on plasmids (Table S2 in Supplementary Material). 
All unique genes for L. plantarum TIFN101 and L. plantarum 
CIP104448 compared to WCFS1 are listed in Tables S3 and S4 in 
Supplementary Material, and all absent genes in the two strains 
are listed in Tables S5 and S6 in Supplementary Material, respec-
tively, as these are potential candidate genes for the biological 
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effects of the two strains. L. plantarum CIP48 lacks the complete 
plantaricin biosynthesis gene cluster, a large set of genes adjacent 
to this cluster (i.e., OGs 334–348), and the entire gene cluster 
for EPS biosynthesis. L. plantarum TIFN101 is missing some 
genes associated with plantaricin biosynthesis as well as genes for 
exopolysaccharide biosynthesis, many sugar utilization cassettes, 
and two large LPXTG-anchored mucus-binding proteins (Tables 
S7A,B in Supplementary Material).
DiSCUSSiOn
The current experimental human study was undertaken to 
investigate the immunomodulatory and potentially beneficial 
effects of three L. plantarum strains, which were selected in vitro 
for their differential immune stimulating capacity. Indicators of 
responses of mucosal and systemic immunity were assessed in 
healthy individuals undergoing a mild, commonly encountered 
stressor (25, 26) of the intestine and immune system, i.e., the 
intake of NSAIDs. We show that three L. plantarum strains had a 
highly strain-dependent effect on immunity in vivo, which were 
different to those predicted in vitro.
Indicators of systemic immunomodulatory effects were 
assessed in peripheral blood samples of the study participants. 
Consumption of indomethacin induced a reduction in CD4+/
Foxp3 regulatory cell frequencies, which was prevented by 
WCFS and TIFN101 administration. This can be considered a 
beneficial regulatory effect. CIP48, not preventing the reduction 
of CD4+Foxp3 and reducing the number of memory cells, had 
effects that suggest a pro-inflammatory effect of consumption 
of this bacterium. Furthermore, T-cell polarization was studied 
FigUrE 8 | Continued
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after different stimuli. The hypothesis was that bacterial cell-wall 
components might induce immune responses (1) and enhance 
systemic immunity as a bystander effect. This happened with 
WCFS and TIFN101 (Figure 5). However, the most pronounced 
stimulator of immunity, i.e., TIFN101, also showed enhanced 
responses against specific pathogenic antigens such as TT and 
had an overall enhanced response to the SEB challenge. It is 
unlikely that the enhanced response against TT in the TIFN101 
consumers is caused solely by the response against TIFN101 
cell components. This is supported by the analysis of the 
intestinal biopsies that suggest that TIFN101 stimulate specific 
processes in the intestinal mucosa. TIFN101, in contrast to 
the other strains, upregulates mucosal transcription processes 
associated with T and B cell function and antigen presentation, 
when compared to placebo. It also had a pronounced effect 
on CD27 upregulation, which is required for generation and 
long-term maintenance of T cell immunity (37). Furthermore, 
TIFN101 enhanced expression of MHC-IIα in intestinal mucosa 
as well as key regulatory molecules such as RAPL. RAPL 
enhances integrin affinity and the adhesion of T cells (38, 39). 
These observations in the mucosa may explain the enhanced 
memory T cell responses observed with TIFN101 consumption. 
Furthermore, B cell immunity in the mucosa was enhanced as 
illustrated by upregulation of immunoglobulin regulatory genes 
and by CD79a. CD79a is also known as B cell antigen receptor 
complex-associated protein alpha-chain forming, together with 
CD79b protein, the B cell antigen receptor complex-associated 
protein (40). CIP48 and WCFS did not have these effects; in fact, 
they had a tendency to downregulate processes such as antigen 
presentation in the mucosa.
FigUrE 8 | Continued
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FigUrE 8 | Regulation of genes involved in antigen presentation in non-steroidal anti-inflammatory drug-stressed intestine after consumption of either Lactobacillus 
plantarum TIFN101 (a), L. plantarum CIP104448 (B), or L. plantarum WCFS1 (C). Red indicates upregulation while green depicts downregulation of the specific 
gene. TIFN101 upregulated MHC-IIα while CIP48 and WCFS1 downregulated MHC-IIβ.
As a consequence of differences in TLR-binding, L. plantarum 
strains induce upon incubation with monocytes or dendritic 
cells different quantities of the pro-inflammatory cytokine 
IL-12 and the regulatory cytokine IL-10 (10). On the basis of 
these findings, three strains were selected, L. plantarum WCFS1 
(WCFS), L. plantarum CIP104448 (CIP48), and L. plantarum 
TIFN101 (TIFN101), as their induced IL-10/IL-12 ratio 
in  vitro were classified as pro-inflammatory, neutral, or anti-
inflammatory, respectively. However, the immune responses to 
these strains in vivo were very different to that predicted in vitro. 
Consumption of NSAID induced a reduction in CD4+/Foxp3 
regulatory cell frequencies, which was prevented by WCFS1 
and TIFN101 administration. This should be considered to be 
a beneficial regulatory effect. CIP48 did not prevent NSAID-
induced reduction of CD4+Foxp3 T cells and had more negative 
effects. CIP48 reduced the number of memory cells suggesting 
a pro-inflammatory, worsening effect of consumption of this 
bacterium. Our data suggest that solely studying the effects of 
bacteria on a single cell type in vitro, such as dendritic cells, has 
limited value, as it does not provide representative insight into 
the complex interplay between immune and other mucosal cells 
in vivo.
To our knowledge, this is the first report that bacteria can 
downregulate snoRNAs in the stressed intestine. SnoRNA are 
metabolically stable, non-coding RNAs that associate with a 
set of proteins to form small nucleolar ribonucleoproteins. 
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FigUrE 9 | Continued
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FigUrE 10 | Venn diagram of shared and unique genes in all contigs of 
Lactobacillus plantarum strains [L. plantarum WCFS1 (WCFS), L. plantarum 
CIP104448 (CIP48), L. plantarum TIFN101]. The smaller numbers in italics 
represent ortholog groups that do not match to the chromosome of strain 
WCFS. These numbers do not include the putative prophage genes in each 
genome.
FigUrE 9 | Regulation of genes involved in leukocyte extravasation pathways in non-steroidal anti-inflammatory drug-stressed intestine after consumption of either 
Lactobacillus plantarum TIFN101 (a), L. plantarum CIP104448 (B), or L. plantarum WCFS1 (C). Red indicates upregulation while green depicts downregulation of 
the specific gene.
The majority of snoRNAs function to guide RNAs in the post-
transcriptional synthesis of 2′-O-methylated nucleotides and 
pseudo-uridines in ribosomal RNAs (rRNAs), small nuclear 
RNAs, and other cellular RNAs, including messenger RNAs 
(41–43). The relative reduction of several snoRNAs by TIFN101 
and WCFS suggest a downregulation of methylation of rRNA 
(44) and downregulation of 14b diminished pseudo-uridinila-
tion of RNA (45). Usually, this is indicative of a destabilization 
of cellular processes, but it may also be an indicator of tissue 
repair (46).
It should be noted that, in the present trial, we used a cross-
over design to eliminate potential influences of inter-subject 
differences. Previous interventions may influence subsequent 
tests in such a study design. However, a long wash-out period of 
4 weeks was chosen and the order of interventions was randomly 
assigned to each study subject, which should have minimized 
potential influences between interventions. Furthermore, the 
impact of L. plantarum consumption observed in this study may 
be caused by direct effects on host immunity; however, indirect 
effects via modulation of the resident microbiota may contribute 
as well.
Finally, full genome sequencing of L. plantarum CIP48 and 
L. plantarum TIFN101 was applied to identify possible gene 
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clusters that might be responsible for the differential biologi-
cal effects of the three L. plantarum strains. Several 100 novel 
L. plantarum genes were found in strain CIP48 and TIFN101 
as compared to the known genome of strain WCFS (35, 36), 
of which only a small number are shared by both CIP48 
and TIFN101. The majority of the novel genes appear to be 
located on plasmids. CIP48 appears to have several plasmids 
that are not present in TIFN101 or WCFS. Strain CIP48 has 
specific genes, such as for lantibiotic biosynthesis and several 
cell-surface proteins, that might explain its differential effect. 
Notably, however, there are also numerous genes/gene clusters 
in L. plantarum CIP48 and TIFN101 that are not present in 
the WCFS genome. Strikingly, CIP48 completely and TIFN101 
partially lack the plantaricin biosynthesis clusters. These genes 
have been linked to strain differences in cytokine production 
(10, 47), but were shown here not to be associated with immune 
effects in vivo. Also, both strains lack very large regions important 
for sugar metabolism. These differences have been attributed to 
adaptations to environmental factors which, in our opinion, are 
interesting targets genes and possibly associated with probiotic 
effects (48). Not only the presence but also the absence of genes 
may enhance immune effects of bacteria (8).
COnClUSiOn
The current randomized double-blind placebo-controlled cross-
over human trial demonstrated immune modulatory effects 
by orally consumed L. plantarum strains via specific responses 
against bacterial components as well as direct stimulation of 
specific immunity in the intestine. Specific bacteria can influ-
ence and possibly prevent undesired immune responses during 
commonly encountered stressors of the intestine such as intake 
of NSAIDs. Strong strain-dependent effects were found that 
showed L. plantarum TIFN101 to have a positive effect on host 
immunity, while CIP48 and WCFS1 had effects that may to be 
considered as less beneficial. Caution should be taken in selecting 
beneficial bacteria as even closely related strains can have very 
different effects. The observation that some bacteria can enhance 
specific memory cell populations can be helpful in identifying 
putative immune active human applicable bacterial strains. 
Furthermore, the current comparative genomics study provides 
many leads for follow-up experimental work to identify genes 
that are responsible for or involved in the observed differences in 
immune effects in humans.
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